Blood Stream Infection Testing Market Research Report 2013-2025
Global Blood Stream Infection Testing Market Report, History and Forecast 2013-2025, Breakdown Data by Companies, Key Regions, Types and Application
City of Industry, CA -- (SBWire) -- 07/13/2018 --This report studies the Blood Stream Infection Testing market size by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.
Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/573770/global-blood-stream-infection-testing-market
Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests are SepsiTest, SeptiFast, MagicPlex, VYOO, and PLEX-ID. The global bloodstream infection testing market is driven by the growing incidence and prevalence of burn/wounds cases, HIV, pneumonia, pyelonephritis, and cancer. Additionally, awareness about hygiene, diagnosis rate, unhealthy lifestyle, and increase in geriatric population are the potential factors for the market growth. On the other hand, rigid regulatory scenario regarding diagnosis procedures, high diagnosis cost, and lack of medical reimbursement may hinder the growth of the market during the forecast period. Innovations, R&D investments, mergers and acquisitions among the key vendors are the dynamics for the bloodstream infection testing market to progress.
North America accounts for the largest market share of the global market owing to factors such as high infection rate, increase in awareness, high diagnosis rate, favorable medical reimbursement scenario, and developed medical facilities. It is followed by Europe in terms of market share. Asia Pacific is anticipated to hold the third largest market share owing to large population pool and poor hygienic sense. Latin America and Middle East & Africa are the silent contributors of the market.
In 2017, the global Blood Stream Infection Testing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% between 2018 and 2025.
Ask for Discount on Research Report@ https://www.qyresearch.com/request-discount/form/573770/global-blood-stream-infection-testing-market
This report focuses on the global top players, covered
BD
bioMérieux
Cepheid
Roche Diagnostics
IRIDICA
Bruker
Nanosphere
Siemens
AdvanDX
Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa
Market segment by Type, the product can be split into
Conventional Blood Culture Tests
PCR Methods
Nucleic Acid Testing
Mass Spectroscopy
Point of Care Testing
Market segment by Application, the market can be split into
Hospitals
Independent Diagnostic Centers
Others
Media Relations Contact
Rahul Singh
Director - Digital Marketing
QY Research, INC.
1-626-295-2442
https://www.qyresearch.com
View this press release online at: http://rwire.com/1009006